Docoh
Loading...

LABP Landos Biopharma

80 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
LABP Landos Biopharma Inc
13 Jan 22
Results of Operations and Financial Condition
8:50am
4
LABP Landos Biopharma Inc
21 Dec 21
Landos Biopharma / PATRICIA L BITAR ownership change
4:22pm
4
Timothy M Mayleben
21 Dec 21
Landos Biopharma / TIMOTHY M MAYLEBEN ownership change
4:21pm
8-K
LABP Landos Biopharma Inc
21 Dec 21
Departure of Directors or Certain Officers
4:05pm
4
Josep Bassaganya-Riera
20 Dec 21
Landos Biopharma / Josep Bassaganya-Riera ownership change
5:20pm
4
Josep Bassaganya-Riera
15 Dec 21
Landos Biopharma / Josep Bassaganya-Riera ownership change
5:14pm
4
Josep Bassaganya-Riera
10 Dec 21
Landos Biopharma / Josep Bassaganya-Riera ownership change
8:06pm
4
Josep Bassaganya-Riera
8 Dec 21
Landos Biopharma / Josep Bassaganya-Riera ownership change
5:22pm
4
Josep Bassaganya-Riera
3 Dec 21
Landos Biopharma / Josep Bassaganya-Riera ownership change
6:35pm
4
Josep Bassaganya-Riera
1 Dec 21
Landos Biopharma / Josep Bassaganya-Riera ownership change
9:57pm
4
Jyoti Chauhan
18 Nov 21
Landos Biopharma / Jyoti Chauhan ownership change
4:07pm
3
LABP Landos Biopharma Inc
16 Nov 21
Landos Biopharma / PATRICIA L BITAR ownership change
4:04pm
8-K
LABP Landos Biopharma Inc
15 Nov 21
Landos Biopharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update
8:27am
10-Q
2021 Q3
LABP Landos Biopharma Inc
14 Nov 21
Quarterly report
7:00pm
8-K
LABP Landos Biopharma Inc
10 Nov 21
Departure of Directors or Certain Officers
4:49pm
8-K
LABP Landos Biopharma Inc
3 Nov 21
Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of Rheumatoid Arthritis
8:00am
8-K
LABP Landos Biopharma Inc
28 Oct 21
Landos Biopharma Announces First Subject Dosed in a Phase 1 Study of LABP-104 for Systemic Lupus Erythematosus
4:01pm
8-K
LABP Landos Biopharma Inc
12 Oct 21
Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of Systemic Lupus Erythematosus
8:05am
8-K
LABP Landos Biopharma Inc
8 Oct 21
Regulation FD Disclosure
8:00am
8-K
LABP Landos Biopharma Inc
22 Sep 21
Regulation FD Disclosure
8:00am